Release Date: 09/09/21 16:46 Summary: Off-market buy-back to commence 20 September Price Sensitive: Yes Download Document 276.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%